title: Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor.
authors.forename: V
authors.initials: V
authors.lastname: Sayag-Boukris
authors.forename: J M
authors.initials: JM
authors.lastname: Ziza
authors.forename: P
authors.initials: P
authors.lastname: Brice
authors.forename: B
authors.initials: B
authors.lastname: Wechsler
mesh_terms: D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D000741:Anemia, Aplastic / Q000139:chemically induced*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D017612:Gold Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018501:Antirheumatic Agents; D017612:Gold Compounds; D008727:Methotrexate